Search Results

Filter
  • 1-10 of  115,272 results for ""Myelodysplastic Syndromes""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/classification ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics

  • Source: The Lancet. Haematology [Lancet Haematol] 2024 Nov; Vol. 11 (11), pp. e862-e872. Date of Electronic Publication: 2024 Oct 09.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype.

  • Authors : Huang N; Department of Hematology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Chang C

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis ; Mutation*

  • Source: Annals of hematology [Ann Hematol] 2024 Nov; Vol. 103 (11), pp. 4485-4495. Date of Electronic Publication: 2024 Sep 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Increased ferroptosis of erythrocytes is associated with myelodysplastic syndromes.

  • Authors : Zhang M; Department of Hematology, General Hospital, Tianjin Medical University, 154 Anshandao, Heping District, Tianjin, 300052, China.; Liu M

Subjects: Ferroptosis* ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/pathology ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/metabolism

  • Source: Annals of hematology [Ann Hematol] 2024 Oct; Vol. 103 (10), pp. 4009-4020. Date of Electronic Publication: 2024 Aug 23.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Monitoring molecular changes in the management of myelodysplastic syndromes.

  • Authors : Duployez N; Laboratory of Haematology, CHU Lille, Lille, France.; U1277 CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), University of Lille, INSERM, Lille, France.

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/therapy ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis

  • Source: British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 772-779. Date of Electronic Publication: 2024 Jun 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.

  • Authors : Wery AR; Department of Hematology, Institut Jules Bordet, Rue Meylemeersch, 90. 1070, Brussels, Belgium. .; Salaroli A

Subjects: Neoplasm, Residual* ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/mortality

  • Source: Annals of hematology [Ann Hematol] 2024 Nov; Vol. 103 (11), pp. 4671-4685. Date of Electronic Publication: 2024 Oct 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-synthetase and myelodysplastic syndromes with deep morphea: an example of shared immunopathogenesis? A case-based review.

  • Authors : Hernández-López A; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Reyna-Juárez Y

Subjects: Myositis*/Myositis*/Myositis*/immunology ; Myositis*/Myositis*/Myositis*/drug therapy ; Myositis*/Myositis*/Myositis*/diagnosis Antisynthetase syndrome

  • Source: Rheumatology international [Rheumatol Int] 2024 Nov; Vol. 44 (11), pp. 2645-2652. Date of Electronic Publication: 2024 Sep 09.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comprehensive analysis of a necroptosis-associated diagnostic signature for myelodysplastic syndromes based on single-cell RNA-seq and bulk RNA-seq.

  • Authors : Zhang H; Department of Hematology, the First Hospital of Hebei Medical University, Shijiazhuang, China. .; Department of Hematology, Shijiazhuang Ping'an Hospital, Shijiazhuang, China. .

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis ; Necroptosis*/Necroptosis*/Necroptosis*/genetics

  • Source: Hereditas [Hereditas] 2024 Oct 15; Vol. 161 (1), pp. 38. Date of Electronic Publication: 2024 Oct 15.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 0374654 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses.

  • Authors : DiNardo CD; Departament of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Verma D

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/drug therapy ; Glutaminase*/Glutaminase*/Glutaminase*/antagonists & inhibitors ; Azacitidine*/Azacitidine*/Azacitidine*/therapeutic use

  • Source: Nature cancer [Nat Cancer] 2024 Oct; Vol. 5 (10), pp. 1515-1533. Date of Electronic Publication: 2024 Sep 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow.

  • Authors : Gerlevik S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Seymen N

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/immunology ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Inflammation*/Inflammation*/Inflammation*/genetics

  • Source: ELife [Elife] 2024 Sep 05; Vol. 13. Date of Electronic Publication: 2024 Sep 05.Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromes.

  • Authors : Gulei D; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Moisoiu V

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/drug therapy ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/pathology

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Sep; Vol. 28 (18), pp. e70078.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934

Record details

×
  • 1-10 of  115,272 results for ""Myelodysplastic Syndromes""